Mr. Jacek Antas reports

HELIX BIOPHARMA CORP. ANNOUNCES APPOINTMENT OF NEW CHIEF FINANCIAL OFFICER

Helix BioPharma Corp. has appointed Praveen Varshney as chief financial officer and corporate secretary.

Mr. Varshney has been a principal of Varshney Capital Corp., a Vancouver-based family office, since 1991. He is also a founding director of Pyfera Growth Capital and a founding director of Humanitas Smart Planet Fund, both with a social impact focus. Mr. Varshney obtained his UBC Sauder BComm in 1987 and is an FCPA and FCA. He has been a member of the Vancouver chapter of EO since 1996 and a founding director and charter member of TiE Vancouver since 2000.

He has been a co-founder, director or officer of many publicly traded and private companies over the years, including Mogo Inc. and Little Kitchen Academy. He's also on three charity boards such as the Vancouver Foundation and Foundations for Social Change.

Mr. Varshney is also a recipient of Business in Vancouver's 40 Under 40 Awards, the 2020 Greater Vancouver Board of Trade Wendy McDonald Diversity Awards Outstanding Mentor, and 2021 inaugural, 2022 and 2023 Business in Vancouver Top 500 Most Influential Business Leaders in British Columbia (banking and finance -- private equity, venture capital and hedge funds category).

About Helix BioPharma Corp.

Helix BioPharma is a clinical-stage biopharmaceutical company developing unique therapies in the field of immune-oncology for the prevention and treatment of cancer based on its proprietary technological platform, DOS47. Helix is listed on the Toronto Stock Exchange under the symbol HBP.

We seek Safe Harbor.